SURFACE ONCOLOGY INC's ticker is SURF and the CUSIP is 86877M209. A total of 36 filers reported holding SURFACE ONCOLOGY INC in Q3 2019. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $38,889 | +199.1% | 44,721 | +267.4% | 0.00% | – |
| Q3 2022 | $13,000 | -35.0% | 12,172 | 0.0% | 0.00% | – |
| Q2 2022 | $20,000 | -92.8% | 12,172 | -87.1% | 0.00% | – |
| Q1 2022 | $278,000 | -34.0% | 94,404 | +7.3% | 0.00% | – |
| Q4 2021 | $421,000 | -36.8% | 87,954 | 0.0% | 0.00% | – |
| Q3 2021 | $666,000 | +7.8% | 87,954 | +6.3% | 0.00% | – |
| Q2 2021 | $618,000 | +537.1% | 82,717 | +688.5% | 0.00% | – |
| Q4 2020 | $97,000 | +32.9% | 10,490 | 0.0% | 0.00% | – |
| Q3 2020 | $73,000 | +23.7% | 10,490 | -49.8% | 0.00% | – |
| Q2 2019 | $59,000 | -71.8% | 20,914 | -52.2% | 0.00% | – |
| Q1 2019 | $209,000 | +14.2% | 43,793 | +1.7% | 0.00% | – |
| Q4 2018 | $183,000 | -50.8% | 43,082 | +26.9% | 0.00% | – |
| Q3 2018 | $372,000 | -28.2% | 33,946 | +7.0% | 0.00% | – |
| Q2 2018 | $518,000 | – | 31,728 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Atlas Venture Associates IX, LLC | 2,945,453 | $22,297,000 | 7.41% |
| ACT CAPITAL MANAGEMENT, LLC | 170,500 | $1,291,000 | 0.67% |
| SummerHaven Investment Management, LLC | 128,078 | $970,000 | 0.57% |
| Parkman Healthcare Partners LLC | 248,267 | $1,879,000 | 0.48% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 50,000 | $379,000 | 0.21% |
| C M BIDWELL & ASSOCIATES LTD | 33,030 | $250,000 | 0.17% |
| ARK Investment Management | 4,618,354 | $34,961,000 | 0.08% |
| Knights of Columbus Asset Advisors LLC | 114,594 | $867,000 | 0.08% |
| Orbimed Advisors | 909,666 | $6,886,000 | 0.08% |
| HighVista Strategies LLC | 13,932 | $105,000 | 0.07% |